Terms: = Gastric cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
109 results:
1. Mitochondrial dysfunction induced by HIF-1α under hypoxia contributes to the development of gastric mucosal lesions.
Xiao Y; Liu X; Xie K; Luo J; Zhang Y; Huang X; Luo J; Tan S
Clin Transl Med; 2024 Apr; 14(4):e1653. PubMed ID: 38616702
[TBL] [Abstract] [Full Text] [Related]
2. YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance.
Yang J; Chen Y; He Y; Da M
Drug Dev Res; 2024 Apr; 85(2):e22179. PubMed ID: 38616512
[TBL] [Abstract] [Full Text] [Related]
3. Morusin suppresses the stemness characteristics of gastric cancer cells induced by hypoxic microenvironment through inhibition of HIF-1α accumulation.
Chen M; Xiao S; Sun P; Li Y; Xu Z; Wang J
Toxicon; 2024 Apr; 241():107675. PubMed ID: 38432611
[TBL] [Abstract] [Full Text] [Related]
4. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract] [Full Text] [Related]
5. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
6. TH-302-loaded nanodrug reshapes the hypoxic tumour microenvironment and enhances PD-1 blockade efficacy in gastric cancer.
Wang Z; Zhu M; Dong R; Cao D; Li Y; Chen Z; Cai J; Zuo X
J Nanobiotechnology; 2023 Nov; 21(1):440. PubMed ID: 37993847
[TBL] [Abstract] [Full Text] [Related]
7. PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.
Hu J; Hameed MR; Agaram NP; Whiting KA; Qin LX; Villano AM; O'Connor RB; Rozenberg JM; Cohen S; Prendergast K; Kryeziu S; White RL; Posner MC; Socci ND; Gounder MM; Singer S; Crago AM
Clin Cancer Res; 2024 Jan; 30(2):450-461. PubMed ID: 37943631
[TBL] [Abstract] [Full Text] [Related]
8. Targeting hypoxia-inducible factor-1 alpha suppresses
Noto JM; Piazuelo MB; Romero-Gallo J; Delgado AG; Suarez G; Akritidou K; Girod Hoffman M; Roa JC; Taylor CT; Peek RM
Gut Microbes; 2023 Dec; 15(2):2263936. PubMed ID: 37828903
[No Abstract] [Full Text] [Related]
9. [Mechanism of Astragali Radix-Curcumae Rhizoma in treating gastric cancer based on network pharmacology and experimental verification].
Tan XY; Tao J; Zhang Y; Gu RX
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5056-5067. PubMed ID: 37802848
[TBL] [Abstract] [Full Text] [Related]
10. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
11. Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse.
Yu M; Pan Q; Li W; Du T; Huang F; Wu H; He Y; Wu X; Shi H
Phytomedicine; 2023 Dec; 121():155045. PubMed ID: 37742526
[TBL] [Abstract] [Full Text] [Related]
12. A positive feedback loop between miR-574-3p and HIF-1α in promoting angiogenesis under hypoxia.
Zhang R; Miao Z; Liu Y; Zhang X; Yang Q
Microvasc Res; 2023 Nov; 150():104589. PubMed ID: 37481161
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning models predict the mTOR signal pathway-related signature in the gastric cancer involving 2063 samples of 7 centers.
Zhang H; Zhuo H; Hou J; Cai J
Aging (Albany NY); 2023 Jun; 15(13):6152-6162. PubMed ID: 37341987
[TBL] [Abstract] [Full Text] [Related]
14. Tumor-derived exosome ElNF1-AS1 affects the progression of gastric cancer by promoting M2 polarization of macrophages.
Ma B; Wang J; Yusufu P
Environ Toxicol; 2023 Sep; 38(9):2228-2239. PubMed ID: 37310109
[TBL] [Abstract] [Full Text] [Related]
15. gastric cancer mesenchymal stem cells via the CXCR2/HK2/PD-L1 pathway mediate immunosuppression.
Huang C; Chen B; Wang X; Xu J; Sun L; Wang D; Zhao Y; Zhou C; Gao Q; Wang Q; Chen Z; Wang M; Zhang X; Xu W; Shen B; Zhu W
Gastric Cancer; 2023 Sep; 26(5):691-707. PubMed ID: 37300724
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
Shirvaliloo M
Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
[TBL] [Abstract] [Full Text] [Related]
17. Effect of hypoxia on HIF
Wang L; Xing W; Qi J; Lu Y; Xiang L; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1629-1636. PubMed ID: 36748372
[TBL] [Abstract] [Full Text] [Related]
18. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract] [Full Text] [Related]
19. S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.
Zhong C; Niu Y; Liu W; Yuan Y; Li K; Shi Y; Qiu Z; Li K; Lin Z; Huang Z; Zuo D; Yang Z; Liao Y; Zhang Y; Wang C; Qiu J; He W; Yuan Y; Li B
Adv Sci (Weinh); 2022 Oct; 9(30):e2202206. PubMed ID: 36041055
[TBL] [Abstract] [Full Text] [Related]
20. Pull the plug: Anti-angiogenesis potential of natural products in gastrointestinal cancer therapy.
Ai Y; Zhao Z; Wang H; Zhang X; Qin W; Guo Y; Zhao M; Tang J; Ma X; Zeng J
Phytother Res; 2022 Sep; 36(9):3371-3393. PubMed ID: 35871532
[TBL] [Abstract] [Full Text] [Related]
[Next]
